We evaluated racial/ethnic differences in prevalence of oncogenic HPV types targeted by
the quadrivalent HPV vaccine (16/18) and nonavalent HPV vaccine (31/33/45/52/58) in …

Declines in cervical intraepithelial neoplasia grades 2 to 3 and adenocarcinoma in situ
(CIN2+) observed among young women suggest impact from human papillomavirus (HPV) …

Background We estimated the proportion of cervical intraepithelial neoplasia (CIN) cases
attributed to 14 HPV types, including quadrivalent (qHPV)(6/11/16/18) and 9-valent …

Abstract Background: The New Mexico HPV Pap Registry was established to measure the
impact of cervical cancer prevention strategies in the United States. Before widespread …

Background: The impact of human papillomavirus (HPV) vaccination has been observed in
the United States through declining cervical precancer incidence in young women. To …

Importance A substantial effect of human papillomavirus (HPV) vaccines on reducing HPV-
related cervical disease is essential before modifying clinical practice guidelines in partially …

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV)
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …

Research has demonstrated that the human papillomavirus (HPV) vaccine is a safe and
effective way to decrease HPV-related cervical cancers; however, the vaccination rate in the …

Vaccines that prevent infection with human papillomavirus (HPV) types 16 and 18 that are
known to cause cervical cancer have been available in the United States since 2006. High …

Human papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic
disparities in cervical cancer incidence and mortality in the United States are well …